Trials / Completed
CompletedNCT02952547
Safety and Pharmacokinetics Study of DWC20155 and DWC20156 in Healthy Subjects
A Randomized, Open-label, Oral Dose, Crossover Study to Compare the Safety and Pharmacokinetics Between Co-administration and Fixed Dose Combination of DWC20155 and DWC20156 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study to Compare the safety and pharmacokinetics between co-administration and fixed dose combination of DWC20155 and DWC20156 in healthy subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Co-administration of DWC20155 and DWC20156 | |
| DRUG | DWJ1366 Tab. |
Timeline
- Start date
- 2016-10-30
- Primary completion
- 2016-11-26
- Completion
- 2017-01-10
- First posted
- 2016-11-02
- Last updated
- 2017-02-16
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02952547. Inclusion in this directory is not an endorsement.